drugset / Trial / NCT01731158
Sequential Therapy in Metastatic Renal Cell Carinoma
RandomizedCrossoverOpen-labelTreatment
Summary
Sequential therapy with BEvacizumab, RAd001 (everolimus) and Tyrosinekinase inhibitors (TKI) in metastatic renal cell carcinoma (mRCC)
Timeline
- Start
- 2012-10
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | — | — |
| Subject | Pazopanib | Small molecule | — | — |
| Subject | Sorafenib | Small molecule | — | — |
| Subject | Sunitinib | Small molecule | — | — |
| Background | Bevacizumab | Monoclonal antibody | — | — |
| Background | Interfereon-alfa | Unknown | — | — |